Results 31 to 40 of about 9,107,460 (340)
Reimbursement Contracts: Application of Civil Law Mechanisms under Pandemic Restrictions [PDF]
University Scientific Notes, 2020 The article contextualizes and assesses the peculiarities of using the mechanism of civil law reimbursement of medical expenses in the context of the global spread of acute respiratory infection COVID-19 caused by coronavirus SARS-CoV-2, as well as the theoretical possibility of such coverage of financial costs and revenues through the enforcement of ...
openaire +1 more source
The Use of Diagnosis-Related Group-Based Reimbursement in the Czech Hospital Care System
International Journal of Environmental Research and Public Health, 2021 (1) Background: Diagnosis-Related Groups (DRG), one possibility of a hospital payment system, are currently used in most European countries. Introduced to the Czech system in the 1990s, the DRGs are currently used mainly for care reporting and partly for
Zuzana Kotherová +3 more
semanticscholar +1 more source
Measuring quality in primary healthcare – opportunities and weaknesses
Slovenian Journal of Public Health, 2019 The easy access to data from electronic patient records has made using this type of data in pay-for-performance systems increasingly common. General practitioners (GPs) throughout Europe oppose this for several reasons. Not all data can be used to derive
Arvidsson Eva +2 more
doaj +1 more source
Economic evaluation in stratified medicine: methodological issues and challenges
Frontiers in Pharmacology, 2016 Background: Stratified Medicine (SM) is becoming a practical reality with the targeting of medicines by using a biomarker or genetic-based diagnostic to identify the eligible patient sub-population. Like any healthcare intervention, SM interventions have
Hans-Joerg eFugel +3 more
doaj +1 more source
Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices [PDF]
, 2014 A recurring, foundational issue for evidence-based regulation is deciding whether to extend governmental approval from an existing use with sufficient current evidence of safety and efficacy to a novel use for which such evidence is currently lacking ...
Abbott, Ryan, Ayres, Ian
core +3 more sources
Bundled Payment vs. Fee-for-Service: Impact of Payment Scheme on Performance [PDF]
, 2017 Healthcare reimbursements in the United States have been traditionally based on a fee-for-service (FFS) scheme, providing incentives for high volume of care, rather than efficient care.
Adida, Elodie +2 more
core +2 more sources
Health Policy OPEN, 2021 Highlights • Generic policies are key to realising macroeconomic and microeconomic efficiency objectives.• Generic pricing policies should maximise price difference between generics and originators.• Price capping and tendering should be used more ...
B. Kamphuis, P. Kanavos
semanticscholar +1 more source
Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison
Healthcare, 2021 This study aimed to analyze four current pathways affecting the listing and post-listing prices of new orphan drugs (ODs) in South Korea. These mechanisms were: (1) essential OD, (2) pharmacoeconomic evaluation (PE) waiver OD, (3) weighted average price ...
Jong Hyuk Lee
semanticscholar +1 more source
Addressing Pressing Needs in the Development of Advanced Therapies
Frontiers in Bioengineering and Biotechnology, 2017 The commercial development of advanced therapy medicinal products (ATMPs) represents great opportunity for therapeutic innovation but is beset by many challenges for its developers. Although the ATMP field continues to progress at a rapid pace, evidenced
David Morrow +2 more
doaj +1 more source
Health Policy, 2020 INTRODUCTION The pipeline of new antibacterials remains limited. Reasons include low research investments, limited commercial prospects, and scientific challenges.
D. Gotham +5 more
semanticscholar +1 more source